On September 26, in order to actively respond to the country’s strategic deployment on cultivating specialized, sophisticated and innovative enterprises, and implement the relevant documents of the China Securities Regulatory Commission, the Ministry of Industry and Information Technology and the Shanghai Municipal Government, and in combination with the latest financial support for high-quality economic development measures, the Shanghai Equity Custody and Trading Center and the Yangtze River Delta Specialized, Precision and New Industrial Base jointly held the “Empowering Enterprises to Develop High-Quality” (First Phase) – Entering the Shanghai Stock Exchange. Liu Hongbo, Chairman of Shanghai Kangding Medical Devices Co., Ltd. and four others were invited to attend, and more than 70 high-quality enterprise representatives attended the event.

At the event, six companies including Shanghai Kangding Medical Devices Co., Ltd., witnessed by all parties, rang the gong for listing and officially landed on the Shanghai Specialized Special Board (Shanghai Equity Exchange Center). This move marks that the company has successfully connected with the capital market and will enjoy various financial services and support provided by the special board. As one of the listed companies, Shanghai Kangding Medical Devices Co., Ltd. is a high-tech enterprise focusing on the research and development, production, sales and technical services of orthopedic medical devices. It is committed to the research and development and production of orthopedic medical devices. The product line covers orthopedic trauma, spinal implants, surgical instruments, etc., focusing on internal and external fixation products for limb orthopedics, pediatric orthopedics, and foot and ankle surgery. The company’s scientific research personnel account for 26.58%, focusing on “integration of medicine and engineering”, and widely cooperate with domestic and foreign clinical medicine, biomechanics, materials science, system control, electronic communications and other institutions and experts, continuous R&D investment and technological innovation, and exploration of new technologies, new processes and new products. The company has a total of 17 registration certificates for Class II and Class III medical devices, has participated in the formulation of national standards and industry standards many times, and has obtained more than 30 intellectual property certificates such as software copyrights, national utility models and invention patents. It has established 3 Shanghai-level engineering technology research sub-centers and innovation sub-centers, and 1 Songjiang District-level enterprise technology center. It has also won the second prize of the National Science and Technology Progress Award, the G60 Top 100 Science and Technology Driven Enterprises, and the first Shanghai Medical Device Manufacturing Enterprise Outstanding Manager Representative Evaluation Award.